tiprankstipranks
Advertisement
Advertisement
BridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
PremiumWeekend UpdatesBridgeBio, Dave, Marvell, Filana, GE Trending With Analysts
16d ago
BridgeBio price target raised to $98 from $94 at Morgan Stanley
Premium
The Fly
BridgeBio price target raised to $98 from $94 at Morgan Stanley
18d ago
Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data
Premium
Ratings
Analyst Lifts BridgeBio Price Target to $98 as BBP‑418 Becomes Core Growth Driver Following Strong Phase 3 Data
19d ago
BridgeBio downgraded to Market Perform from Outperform at Raymond James
PremiumThe FlyBridgeBio downgraded to Market Perform from Outperform at Raymond James
20d ago
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
Premium
The Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
27d ago
BridgeBio initiated with a Neutral at Citi
Premium
The Fly
BridgeBio initiated with a Neutral at Citi
28d ago
BridgeBio Pharma Signals Atruvio‑Led Turnaround
PremiumCompany AnnouncementsBridgeBio Pharma Signals Atruvio‑Led Turnaround
1M ago
BridgeBio price target raised to $130 from $125 at Evercore ISI
Premium
The Fly
BridgeBio price target raised to $130 from $125 at Evercore ISI
1M ago
BridgeBio price target lowered to $94 from $98 at Morgan Stanley
Premium
The Fly
BridgeBio price target lowered to $94 from $98 at Morgan Stanley
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100